Breaking News

Aenova Opens New Building for Highly Potent Drugs

Makes total investment of around €25 million at the Regensburg site to increase development and production capacities.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Cytotoxics and cytostatics are in increased demand in the global pharmaceutical market. To meet this steadily increasing demand, Aenova, a leading development service provider and contract manufacturer for the pharmaceutical and healthcare industries, has built a new building at its Regensburg site for the development and production of highly effective active pharmaceutical ingredients (APIs). The total investment of around €25 million will enable the company to expand its production of highly p...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters